Vaccine-Induced T Cell Receptor T Cell Therapy Targeting a Glioblastoma Stemness Antigen

Researchers identified a therapeutic HLA-A*02-restricted protein tyrosine phosphatase receptor type Z1-reactive T cell receptor retrieved from a vaccinated glioblastoma patient.